B&D White Capital Company, LLC Abb Vie Inc. Transaction History

B&D White Capital Company, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$137.6 - $154.97 $9.67 Million - $10.9 Million	70,273 New	70,273 $10.9 Million
Q2 2023 Aug 04, 2023	BUY	$132.51 - $164.9 $39.8 Million - $49.5 Million	300,248 New	300,248 $40.5 Million
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $4.89 Million - $5.87 Million	-35,375 Reduced 75.47%	11,500 $1.86 Million
Q3 2022 Oct 26, 2022	BUY	$134.21 - $153.93 $4.55 Million - $5.21 Million	33,875 Added 260.58%	46,875 $6.29 Million
Q2 2022 Jul 14, 2022	BUY	$137.62 - $174.96 $27,524 - $34,992	200 Added 1.56%	13,000 $1.99 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $238,091 - $295,405	-1,804 Reduced 12.35%	12,800 $2.08 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $3.72 Million - $4.71 Million	-34,626 Reduced 70.34%	14,604 $1.98 Million
Q3 2021 Oct 27, 2021	BUY	$106.4 - $120.78 $3.88 Million - $4.4 Million	36,430 Added 284.61%	49,230 $5.31 Million
Q2 2021 Aug 05, 2021	SELL	$105.21 - $117.21 $31,562 - $35,163	-300 Reduced 2.29%	12,800 $1.44 Million
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $613,800 - $675,720	-6,000 Reduced 31.41%	13,100 $1.41 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $1.54 Million - $2.08 Million	19,100 New	19,100 $2.05 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of B&D White Capital Company, LLC, based on Form 13F filings with the SEC.

Stay updated on B&D White Capital Company, LLC with notifications on news.